NM_001205293.3:c.1055+23134T>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001205293.3(CACNA1E):c.1055+23134T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 151,904 control chromosomes in the GnomAD database, including 24,130 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.56   (  24130   hom.,  cov: 30) 
Consequence
 CACNA1E
NM_001205293.3 intron
NM_001205293.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.0270  
Publications
2 publications found 
Genes affected
 CACNA1E  (HGNC:1392):  (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011] 
CACNA1E Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.733  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | ENST00000367573.7 | c.1055+23134T>C | intron_variant | Intron 7 of 47 | 1 | NM_001205293.3 | ENSP00000356545.2 | |||
| CACNA1E | ENST00000360108.7 | c.1055+23134T>C | intron_variant | Intron 7 of 46 | 5 | ENSP00000353222.3 | ||||
| CACNA1E | ENST00000367570.6 | c.1055+23134T>C | intron_variant | Intron 7 of 46 | 1 | ENSP00000356542.1 | ||||
| CACNA1E | ENST00000621791.4 | c.1055+23134T>C | intron_variant | Intron 7 of 45 | 1 | ENSP00000481619.1 | ||||
| CACNA1E | ENST00000524607.6 | c.1490+23134T>C | intron_variant | Intron 9 of 11 | 5 | ENSP00000432038.2 | 
Frequencies
GnomAD3 genomes  0.558  AC: 84628AN: 151786Hom.:  24103  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
84628
AN: 
151786
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.558  AC: 84692AN: 151904Hom.:  24130  Cov.: 30 AF XY:  0.560  AC XY: 41533AN XY: 74222 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
84692
AN: 
151904
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
41533
AN XY: 
74222
show subpopulations 
African (AFR) 
 AF: 
AC: 
18958
AN: 
41412
American (AMR) 
 AF: 
AC: 
8059
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2109
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
3883
AN: 
5160
South Asian (SAS) 
 AF: 
AC: 
1965
AN: 
4804
European-Finnish (FIN) 
 AF: 
AC: 
6716
AN: 
10536
Middle Eastern (MID) 
 AF: 
AC: 
135
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
41204
AN: 
67940
Other (OTH) 
 AF: 
AC: 
1112
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1860 
 3720 
 5580 
 7440 
 9300 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 724 
 1448 
 2172 
 2896 
 3620 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1895
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.